NKTR Nektar Therapeutics

$69.76▼ -1.26% Healthcare Other
After hours $70.20▲ +0.63% Sep 11, 7:33 PM ET
Volume 680.6K Avg Volume (10D) 603.0K
Key Metrics & Fundamentals
Market Cap
$2.38B
P/E Ratio
–
Div Yield
–%
52W Range
33.40 - 109.00
% vs 50 MA
-3.35%
% vs 200 MA
6.97%
RSI-14
42.0
MACD Histogram
-0.5300
Beta (1Y vs SPY)
1.21
Free Cash Flow
-$75.86M
Gross Rev
$10.13M
Gross Profit
$10.13M
EBITDA
-$32.36M
COGS
–
Operating Exp
$51.89M
Operating Income
-$41.76M
EBIT
-$41.76M
Pretax Income
-$40.30M
Net Income
-$40.62M
EPS (Diluted)
-1.23
Price & Volume History
Loading chart…
Recent News
Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire · Aug 28, 2026 8:15 PM
Nektar’s (NKTR) Billion-Dollar Balance Sheet Faces A Multi-Year Test
Insider Monkey · Aug 27, 2026 1:56 PM
Nektar Announces Publication in The Lancet of Positive Phase 2b REZOLVE-AD 16-Week Induction Results of Rezpegaldesleukin in Moderate-to-Severe Atopic Dermatitis
PR Newswire · Aug 25, 2026 12:30 PM
Nektar (NKTR) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 20, 2026 11:34 PM
Nektar Therapeutics (NKTR) Could Be 52% Undervalued After Q2 Earnings Surprise
Simply Wall St. · Aug 15, 2026 2:09 AM
Nektar Therapeutics (NKTR) Stock Looks Stretched Despite New Phase 3 Trial Launch
Simply Wall St. · Aug 14, 2026 3:12 PM
Retail Sales Weaken in July
Zacks · Aug 14, 2026 2:36 PM
U.S. Stock Futures Mixed, Heads for a Winning Week
Zacks · Aug 14, 2026 2:29 PM
Nektar Therapeutics Q2 2026 Earnings Call Summary
Moby · Aug 14, 2026 12:30 PM
Nektar Therapeutics (NKTR) (Q2 2026) Earnings Call Highlights: Respeg Phase 3 Momentum and ...
GuruFocus.com · Aug 14, 2026 5:01 AM
Financial Overview - Income Statement Quarterly

See NKTR's money flow as a full page

Social Sentiment
Avg +0.64 · 10 posts
TradeDiscussionRoller coaster recovery on my ROTH IRA: $8k to $76k
r/wallstreetbets · Feb 11, 2026
The author experienced a significant recovery driven by NKTR calls, indicating positive sentiment.
positive +0.80
TradeDiscussionRollercoaster recovery on my ROTH IRA
r/wallstreetbets · Feb 11, 2026
The author references a specific trade and the stock's price, indicating a minor positive sentiment.
positive +0.20
NewsDDNektar Therapeutics (NKTR) Strength Attributed to Rumor of Eli Lilly Buyout
r/wallstreetbets · Oct 17, 2025
The post expresses strong belief in a positive catalyst (Eli Lilly buyout) for NKTR, indicating bullish sentiment.
positive +0.70
DDNews[KALV] FDA APPROVED 🚀 | First-in-class oral HAE drug is here — buckle up
r/wallstreetbets · Jul 7, 2025
The post highlights NKTR's past performance as a benchmark for KALV’s potential.
positive +0.80
DDDiscussionTradeNKTR Stock: Short Cover Wave Details | More Upside Ahead | WSB Buy Alert
r/options · Jun 26, 2025
The post uses phrases like 'More Upside Ahead' and 'WSB Buy Alert,' indicating bullish sentiment.
positive +0.70
Page 1 of 2 (10 total)
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙